glp-1 and pregnancy weight-loss drugs pose hidden risks for young women – News Study links GLP-1 use to

Future research should prioritise long-term outcomes in high-risk groups, comparisons of physiological versus pharmacological dosages in healthy subjects, cost-effectiveness analyses, and adherence monitoring to inform clinical guidelines for the management and prevention of B12 deficiency

Endogenous secretory RAGE increases with improvements in body composition and is associated with markers of adipocyte health

However, routine thyroid ultrasound monitoring is not recommended solely due to GLP-1 treatment

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: New mechanistic insights for rapid acting antidepressants